Human Cells Rejuvenated by 60 Years in Lab
A new method reversed more than six decades of cellular aging in human blood cells, offering a fresh tool for aging research.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
Why Clinical Tools That Work Can Still Fail in Real-World Use
A patient case shows how sparse data and care pathways can undermine a well-functioning risk model.
Double-Hit Lymphoma: A Rare, Aggressive DLBCL Subtype Demands Precision
New classification rules and CAR-T therapy data are shifting how this rare, aggressive lymphoma is diagnosed and treated.
Salmonella, Measles, and Ebola Updates Lead Health Roundup
MedPage Today’s roundup covers an oyster-linked Salmonella outbreak, a third measles death in Pennsylvania, and Ebola cases in Nigeria and Kenya.
Roivant's brepocitinib succeeds in uveitis trials, set for FDA filing
Positive Phase 3 results position the already-approved drug as a potential new standard for a blinding eye disease.
Nigeria confirms travel-related Ebola case linked to DRC outbreak
The imported case makes Nigeria the fifth country to report an infection tied to the ongoing Ebola outbreak in the Democratic Republic of the Congo.
Hackensack Meridian and Hunterdon sign merger deal with $230M investment
New Jersey's largest health system moves to absorb Hunterdon Health, pending state and federal approval.
Mark Cuban's Cost Plus Drugs takes on n-of-1 rare disease treatments
Cost Plus Drugs is moving beyond generics to manufacture custom medicines for single patients with rare genetic diseases.
AMA Asks FDA for Risk-Based GenAI Oversight
The American Medical Association wants the FDA to clarify who is accountable for the safety of generative AI in clinical settings.
Can Isomorphic Labs turn AlphaFold into a drugmaking engine?
Alphabet's secretive AI startup is betting its Nobel-winning protein tool can transform drug discovery, but success is far from guaranteed.
Arcus kidney cancer data lifts shares; TriGemX plans SPAC listing
The latest biotech roundup covers promising kidney cancer data, a migraine drug developer going public, and new AI deals for Lilly and AstraZeneca.
Tele-ICU Remote Staffing Linked to Shorter Hospital Stays
A longer-term follow-up study found that hospitals using remote intensivists in the ICU had shorter average hospital stays, with no negative safety signals.
Too Much RNA Can Starve Cells of Energy, New Study Finds
Excess RNA, even normal messenger RNA, can directly damage mitochondria, revealing a previously unknown route by which infections and aging may harm cells.
Less than 25% of mental health provider calls end in appointments, study finds
A new secret shopper study shows that inaccurate directories and unreachable providers keep most insured patients from getting mental health appointments.
Testosterone for Menopause Tied to Higher Heart Risk in Study
A large retrospective study links testosterone therapy in postmenopausal women to a higher risk of cardiovascular events, though authors caution it is not proof of causation.
Ultrasound, Circadian Clues, and GLP-1 Risks in Psychiatry Roundup
A pilot ultrasound trial eased schizophrenia delusions, a quarter of severe depression cases show circadian disruption, and GLP-1 use raises eating-disorder concerns.
ADA's top scientific officer out amid review of June expulsions
The American Diabetes Association's chief scientific and medical officer has left her role with no explanation while the organization's review of a controversial June incident remains unfinished.
CMS Targets Fraud in New York Adult Day Care Program
Federal health officials are using newly granted authority to remove providers from federal programs, targeting New York City adult day care centers accused of widespread fraud.